chr5-96793832-T-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000443439.7(ERAP1):c.1045A>G(p.Met349Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.194 in 1,612,274 control chromosomes in the GnomAD database, including 33,216 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000443439.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERAP1 | NM_001040458.3 | c.1045A>G | p.Met349Val | missense_variant | 6/19 | ENST00000443439.7 | NP_001035548.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERAP1 | ENST00000443439.7 | c.1045A>G | p.Met349Val | missense_variant | 6/19 | 1 | NM_001040458.3 | ENSP00000406304 | P1 | |
ERAP1 | ENST00000296754.7 | c.1045A>G | p.Met349Val | missense_variant | 6/20 | 1 | ENSP00000296754 |
Frequencies
GnomAD3 genomes AF: 0.162 AC: 24678AN: 152128Hom.: 2274 Cov.: 32
GnomAD3 exomes AF: 0.154 AC: 38690AN: 250984Hom.: 3577 AF XY: 0.156 AC XY: 21126AN XY: 135660
GnomAD4 exome AF: 0.198 AC: 288576AN: 1460028Hom.: 30940 Cov.: 35 AF XY: 0.195 AC XY: 141730AN XY: 726424
GnomAD4 genome AF: 0.162 AC: 24695AN: 152246Hom.: 2276 Cov.: 32 AF XY: 0.160 AC XY: 11899AN XY: 74448
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at